By Marc Phu · Cosmetics Product Development & Ingredients · Published 30 Jun 2026
Dr. Myron Wentz had already built and sold one successful science company before he founded USANA Health Sciences in 1992. A microbiologist and immunologist who pioneered cell culture diagnostic techniques, Wentz used the proceeds from selling his controlling interest in Gull Laboratories, a viral diagnostics company he had founded in 1974, to fund USANA’s creation in West Valley City, Utah. More than three decades later, USANA manufactures and sells supplements, personal care and energy products from its own FDA-registered Salt Lake City facility to 23 global markets.
This profile looks at how a scientist’s second company built its identity around in-house, science-led manufacturing rather than outsourcing production, why USANA chose to keep essentially all manufacturing at a single Utah campus even while selling internationally, and what that concentrated approach can teach other direct-selling nutrition companies about the trade-offs between centralised and distributed production.

Key takeaways
- USANA was founded in 1992 by Dr. Myron Wentz, a microbiologist who funded the new company using proceeds from selling his earlier diagnostics business, Gull Laboratories.
- The company manufactures the large majority of its supplements, personal care and energy products at its own FDA-registered facility in Salt Lake City, Utah, rather than relying primarily on outside contract manufacturers.
- USANA operates on a direct-selling business model, distributing products through independent sales associates across 23 global markets.
- The company opened a dedicated ~43,000-square-foot foods manufacturing facility in Salt Lake City in 2019, expanding its campus alongside its original production and office hub.
- USANA has been repeatedly recognised as a top manufacturer in Utah, a distinction tied directly to the scale of its concentrated, in-house production model.
A scientist’s second company
Dr. Myron Wentz’s path to founding USANA began well before 1992. He established Gull Laboratories in 1974, building a company focused on developing viral diagnostic tools through cell culture methods, a genuinely technical scientific foundation rather than a background in consumer products or direct selling. In 1992, Wentz sold his controlling interest in Gull Laboratories specifically to fund the creation of USANA, moving the underlying diagnostic testing operation from Salt Lake City to West Valley City, Utah, and pivoting toward multi-level marketed nutritional supplements.
Founding a second company in an entirely different consumer category, funded by the sale of a first company built on unrelated scientific expertise, is a distinctive path. It suggests Wentz was less committed to a single specific technology than to applying rigorous scientific methodology, wherever it led him next, to a new commercial opportunity.
Choosing in-house manufacturing over outsourcing
From early in its history, USANA built its own manufacturing capability rather than relying primarily on contract manufacturers, a choice the company has maintained and expanded ever since. In 1995, Wentz announced a new dedicated facility at 2700 South Bangerter Highway in Salt Lake City, and the company has continued investing in that same general campus for manufacturing capacity ever since, including a roughly 43,000-square-foot dedicated foods facility opened in 2019 next to its main office and manufacturing hub.
This concentration is unusual for a direct-selling company operating in 23 global markets: rather than distributing production regionally closer to each major market, USANA has kept the substantial majority of its manufacturing and quality control at a single Utah location, a deliberate choice to prioritise centralised quality control and process consistency over the logistical convenience of regional production.

The trade-offs of centralised versus distributed manufacturing
Concentrating manufacturing at a single site offers real advantages: consistent quality control under one set of standards and one management team, simpler regulatory compliance since only one facility needs FDA registration and inspection, and tighter oversight of formulation consistency across the company’s full product range. The trade-off is longer shipping distances and lead times to serve the company’s 23 international markets from a single U.S. location, compared with a distributed manufacturing model that might place production closer to each regional market.
USANA’s apparent judgment, sustained consistently since the 1990s, is that the quality-control and consistency benefits of centralised manufacturing outweigh the logistical costs of shipping internationally from one facility. For a smaller direct-selling or nutrition brand weighing the same trade-off, USANA’s approach suggests that centralisation is a defensible choice, particularly for a company whose brand is built substantially around scientific rigour and manufacturing consistency, provided the international logistics costs are genuinely manageable at the company’s scale.
International expansion through acquisition, not just exports
Rather than relying solely on exporting Utah-manufactured products into new markets, USANA has selectively used acquisition to establish local capability in specific markets, including its 2013 acquisition of BabyCare Ltd., a China-based prenatal supplement company, alongside an announced plan to build manufacturing capacity within China itself. This reflects a recognition that some markets, China’s prenatal supplement category in this case, warranted local production and local brand equity rather than exporting a Utah-made product under the USANA name alone.
This selective approach, centralised manufacturing as the default with targeted local acquisition or production where a specific market genuinely calls for it, is a more nuanced strategy than either fully centralising or fully localising production everywhere.
Recognition as a top manufacturer in its home state
USANA has been named a top manufacturer in Utah multiple times, a recognition directly tied to the scale and quality standards of its concentrated Salt Lake City production base. The company’s manufacturing facility has also received GFSI certification from SQF, a globally recognised food safety standard, further substantiating the quality-control benefits the company has consistently pointed to as the rationale for keeping production centralised rather than distributed.
For a company built on a direct-selling model, where independent sales associates are effectively vouching for product quality to their own personal networks, this kind of externally verified manufacturing recognition provides a credible, third-party-backed answer to quality questions that might otherwise rest purely on the company’s own marketing claims.
Lessons for OEM and private label brands
Several elements of USANA’s approach apply at a smaller scale. Building in-house manufacturing capability rather than relying entirely on contract manufacturers is a legitimate strategic choice when a brand’s core identity rests on scientific rigour and manufacturing consistency specifically, even though it requires far more capital and operational complexity than outsourcing. Centralising production at a single well-run facility can outperform distributing it regionally, provided the resulting logistics costs remain genuinely manageable. And selectively localising production or acquiring local capability in specific markets that warrant it, rather than applying one global manufacturing strategy uniformly everywhere, allows a more nuanced approach to international expansion.
None of these require USANA’s manufacturing scale. A smaller brand deciding whether to build owned production or continue outsourcing, and considering whether a specific international market might warrant a different approach than its default strategy, is working through the same underlying trade-offs USANA has navigated since the 1990s.
Where the company stands today
USANA Health Sciences remains headquartered and substantially manufactures at its Salt Lake City, Utah campus, selling supplements, personal care and energy products through a direct-selling model across 23 global markets. Its consistent recognition as a top Utah manufacturer, combined with third-party quality certifications, continues to substantiate the centralised, science-led manufacturing approach the company has maintained since Dr. Myron Wentz founded it in 1992.
Direct selling paired with a science-first identity
USANA’s direct-selling model, distributing products through independent associates rather than conventional retail, sits alongside a brand identity built heavily around scientific credibility, in-house manufacturing and clinical-style quality standards. This pairing is not automatic: many direct-selling companies lean primarily on lifestyle or opportunity-focused marketing rather than manufacturing credentials, while USANA has consistently emphasised its own facility’s certifications and Wentz’s scientific background as central to its pitch.
For a brand considering a direct-selling or affiliate distribution model, USANA’s approach suggests that pairing that model with a genuinely substantiated science-and-manufacturing story, rather than relying on the distribution model’s income-opportunity appeal alone, can differentiate a company within a category where that combination is less common than the distribution model by itself.
Frequently asked questions
When was USANA founded and by whom?
USANA was founded in 1992 by Dr. Myron Wentz, a microbiologist who funded the company using proceeds from selling his earlier diagnostics business, Gull Laboratories.
Does USANA manufacture its own products?
Yes. The large majority of USANA’s supplements, personal care and energy products are manufactured at its own FDA-registered facility in Salt Lake City, Utah.
How does USANA sell its products?
Through a direct-selling business model, distributing products via independent sales associates across 23 global markets.
What can a smaller brand learn from USANA’s manufacturing approach?
That building in-house manufacturing and centralising production at one well-run facility can be a defensible strategic choice when a brand’s identity rests on scientific rigour and consistency, provided the resulting logistics costs remain manageable.
Further reading
- USANA Health Sciences — official website
- USANA Health Sciences — Wikipedia
- USANA Investor Relations: Company Information (official)
- For background on how OEM and private label brands typically get built, see our explainer on what OEM manufacturing involves.
- Our OEM Manufacturer category covers other contract manufacturers and industry leaders worth knowing.
This article is an independent editorial profile based on publicly available information. All figures should be verified against the company’s current public disclosures.
About the author
Marc Phu is a China-based professional with experience related to cosmetics and the beauty industry. His background provides an industry perspective on product development, ingredients, innovation and the evolving Chinese beauty market. LinkedIn



